10-2
Art: 714372-00L
Rev. Date: 30-Jul-12
Hemolysis
Avoid hemolysis (bursting of red cells) by
•
allowing residual alcohol to dry over the puncture site
•
discarding a sample from a traumatic draw.
Hemolysis will cause an increase in potassium results and a decrease in
calcium results. For cTnI, CK-MB, and BNP cartridges, gross hemolysis
can also cause a decreased alkaline phosphatase activity and an increased
proteolytic activity, resulting in decreased detection of cTnI, CK-MB, or BNP.
VENIPUNCTURE - pH, PCO
2
, ELECTROLYTE, CHEMISTRY, AND HEMATOCRIT TESTS
Anticoagulants
If the sample can be tested in a cartridge immediately, a plain syringe can
be used. If a cartridge cannot be filled immediately the sample should be
collected in a blood collection tube with sodium heparin or lithium heparin or
a pre-heparinized syringe labeled for measurement of electrolytes and ionized
calcium (such syringes contain balanced or low-level heparin). If manually
heparinizing syringes, the heparin-to-blood ratio should not exceed 10 U
heparin per milliliter of blood. Blood collection tubes contain approximately 15
U/mL when filled to capacity.
Samples collected in EDTA anticoagulant may be used only with the i-
STAT Glucose and BNP cartridges. It may be convenient to collect a single
EDTA tube when testing for glucose and glycated hemoglobin (HbA1c)
simultaneously.
EDTA may not be used with any cartridge type other than
the Glucose or BNP cartridges. EDTA will cause a clinically significant error
in sodium, potassium, chloride and hematocrit results and may affect other
chemistry tests. Do not use an EDTA sample with a cartridge that includes
glucose as part of a panel. Even if only the glucose result is to be used, all
results are stored in the analyzer’s memory and, since results can be printed
and transmitted to a Central Data Station, they can become part of the
patient’s permanent record.
i-STAT BNP cartridges require the use of EDTA whole blood or plasma
samples collected in plastic syringes or evacuated tubes containing EDTA.
The use of glass vessels is not recommended because the BNP molecule has
been shown to be unstable in glass tubes. The use of whole blood or plasma
samples containing other anticoagulants such as heparin, oxalate, and citrate
is not recommended.
Tube Order
Collect blood collection tubes in the prescribed sequence to avoid
interference due to carry-over of additive from one tube to the next:
•
No additive
•
Citrate
•
Heparin
•
EDTA - Na
2
, K
3
or K
2
•
Oxalate, fluoride, iodoacetate
If a citrate tube is drawn, draw a 5mL plain discard tube before drawing the
heparin tube.
Summary of Contents for i-STAT 1
Page 1: ...i STAT 1 System Manual Rev Date 20 Jan 12 Art 714336 00L ...
Page 18: ...1 8 Art 714363 00U Rev Date 02 Aug 12 ...
Page 44: ......
Page 90: ......
Page 106: ...9 12 Art 714371 00E Rev Date 06 Aug 12 ...
Page 162: ......
Page 166: ...Art 730292 00A Rev Date 20 Feb 12 4 ...
Page 176: ...10 10 Art 714372 00L Rev Date 30 Jul 12 ...
Page 182: ...11 6 Art 714373 00F Rev Date 17 Jan 11 ...
Page 184: ...12 2 Art 714374 00J Rev Date 25 Aug 11 ...
Page 185: ...Art 714374 00J Rev Date 25 Aug 11 12 3 ...
Page 186: ...12 4 Art 714374 00J Rev Date 25 Aug 11 ...
Page 187: ...Art 714374 00J Rev Date 25 Aug 11 12 5 ...
Page 192: ......
Page 194: ......
Page 214: ...14 20 Art 714376 00M Rev Date 31 Jan 12 ...
Page 216: ...14 22 Art 714376 00M Rev Date 31 Jan 12 ...
Page 218: ...14 24 Art 714376 00M Rev Date 31 Jan 12 ...
Page 220: ...14 26 Art 714376 00M Rev Date 31 Jan 12 ...
Page 222: ...14 28 Art 714376 00M Rev Date 31 Jan 12 ...
Page 224: ...14 30 Art 714376 00M Rev Date 31 Jan 12 ...
Page 226: ......
Page 236: ......
Page 252: ...17 4 Art 714379 00F Rev Date 18 Jul 12 ...
Page 254: ......
Page 294: ...Art 725768 00E Rev Date 04 Jan 12 20 ...
Page 336: ...22 2 Art 714384 00D Rev Date 07 18 06 ...
Page 342: ...22 8 Art 714384 00D Rev Date 07 18 06 ...
Page 348: ...22 14 Art 714384 00D Rev Date 07 18 06 ...
Page 352: ...22 18 Art 714384 00D Rev Date 07 18 06 ...
Page 364: ...22 30 Art 714384 00D Rev Date 07 18 06 ...
Page 384: ...22 50 Art 714384 00D Rev Date 07 18 06 ...
Page 404: ...22 70 Art 714384 00D Rev Date 07 18 06 ...
Page 488: ...Kaolin ACT 4 Art 715878 00M Rev Date 31 Jan 12 ...
Page 536: ......
Page 556: ...Art 714261 00E Rev Date 10 Jan 11 8 ...
Page 560: ...Art 716240 00D Rev Date 03 Mar 10 4 ...
Page 572: ...Art 715617 00D Rev Date 06 11 08 ...
Page 578: ...Art 714547 00F Rev Date 06 11 08 ...
Page 590: ...Art 720735 00B Rev Date 06 11 08 ...
Page 592: ...Art 721106 00B Rev Date 06 11 08 ...
Page 598: ...Art 722831 00A Rev Date 19 Feb 09 ...
Page 610: ...Art 720654 00B Rev Date 06 11 08 ...
Page 614: ...Art 721317 00D Rev Date 13 Aug 12 4 ...
Page 616: ...Art 725703 00A Rev Date 08 Mar 10 2 ...
Page 618: ...Art 721296 00A Rev Date 07 16 08 ...
Page 620: ...REV DATE 16 Oct 12 ART 714446 00L ...
Page 627: ...PROCEDURE MANUAL FOR THE i STAT SYSTEM 6 REV DATE 16 Oct 12 ART 714446 00L ...
Page 628: ...PROCEDURE MANUAL FOR THE i STAT SYSTEM 7 REV DATE 16 Oct 12 ART 714446 00L ...
Page 629: ...PROCEDURE MANUAL FOR THE i STAT SYSTEM 8 REV DATE 16 Oct 12 ART 714446 00L ...
Page 630: ...PROCEDURE MANUAL FOR THE i STAT SYSTEM 9 REV DATE 16 Oct 12 ART 714446 00L ...
Page 658: ......